Brendan Teehan

Brendan Teehan is our Senior Vice President and Chief Insights & Analytics Officer and has been with Acadia since July 2018. He has more than 25 years of experience in both the United States and Europe. Mr. Teehan joined Acadia from TESARO, Inc., where he served as Vice President, building and leading the Provider Solutions Department. Prior to that, Mr. Teehan launched, XGEVA®, a blockbuster monoclonal antibody, at AMGEN for patients suffering from bone metastases from a variety of cancers. Mr. Teehan launched his career with Johnson & Johnson where he took on multiple commercial roles in the U.S. and Europe across numerous therapeutic categories including oncology, immunology, inflammation, transplantation, COPD and asthma. He has led both field-based and home office teams in the launch of multiple blockbuster products for Johnson & Johnson, Amgen, Rain Tree Oncology, and TESARO. Mr. Teehan received his M.B.A. from Carnegie Mellon University, Tepper School of Business and his Bachelor of Arts degree in Government and International Relations from the University of Notre Dame.